戻る
「早戻しボタン」を押すと検索画面に戻ります。 [閉じる]

コーパス検索結果 (right1)

通し番号をクリックするとPubMedの該当ページを表示します
1                          Self-reported medication adherence was assessed with 2 validated instruments: the Chang scale an
2 take of children participating in a population-based cohort was assessed with a 211-item age-specific FFQ at the ages of
3                                          Cognitive function was assessed with a comprehensive test battery and a global c
4                                            Overall survival was assessed with a group sequential testing procedure and an
5                                           Handgrip strength was assessed with a handgrip dynamometer and skeletal muscle
6 ct of medication adherence on mean deviation (MD) over time was assessed with a linear mixed regression model adjusting f
7 ally, the lipophilicity of trifluorinated glucose analogues was assessed with a log P determination method based on (19)F
8 re determined, and the relationship between smoking and IOP was assessed with a multivariate linear regression model.
9 he presence of SDB (defined as apnea-hypopnea index >=15/h) was assessed with a portable SDB monitor the night before sur
10                                             Each individual was assessed with a screening cognitive test battery and an e
11                                 Active-site function of IXa was assessed with a tripeptidyl substrate (PF-3688).
12 als from Northern Germany (57% male, median age 62 y), diet was assessed with a validated FFQ and an overall, a healthy,
13                                        The hand circulation was assessed with angiography.
14                                 Time to waitlisting or LDKT was assessed with at least 18 months of follow-up.
15  agreement between predicted and actual subgroup membership was assessed with calibration plots.
16                                Presence and severity of VSP was assessed with computed tomography angiography/perfusion i
17                                     Quantification accuracy was assessed with Dice scores, group comparisons and correlat
18                                  Associated clinical impact was assessed with early morbidity and histopathology outcomes
19                                    Risk of publication bias was assessed with Egger's test.
20                                                         MCI was assessed with extensive cognitive tests.
21                                           Valve performance was assessed with fluoroscopy, echocardiography, and histolog
22 clinical characteristics with total hill of vision (V(TOT)) was assessed with general linear models.
23                                           Functional status was assessed with Glasgow Outcome Scale Extended (GOSE) 6, 12
24                                               Repeatability was assessed with inter- and intraobserver comparisons and an
25                                               Reading-speed was assessed with International-Reading-Speed-Texts (IReST) c
26                                   Interobserver reliability was assessed with kappa statistics.
27         The association of early oseltamivir with mortality was assessed with log-binomial models and a competing risks a
28 the principal components to discriminate between phenotypes was assessed with logistic regression.
29          The predictive ability of these imaging parameters was assessed with multivariable Cox regression and formal int
30  The primary endpoint, the GBS disability scale at 4 weeks, was assessed with multivariable ordinal regression.
31        The association between TBS and severe periodontitis was assessed with multivariate binary logistic regression.
32                               Full-mouth periodontal status was assessed with probing depth (PD), clinical attachment los
33                               Subjective exercise intensity was assessed with questionnaire responses.
34                      Vision-related quality of life (VRQOL) was assessed with Rasch revised National Eye Institute Visual
35                               Progression through IFE steps was assessed with survival analysis.
36 ality of 8041 participants of the Whitehall II cohort study was assessed with the Alternative Healthy Eating Index 2010 (
37                                      Prediction performance was assessed with the area under the receiver operating chara
38                                               Study quality was assessed with the Centre for Evidence-Based Management (C
39                                                 Maternal CM was assessed with the Childhood Trauma Questionnaire Maternal
40 reported here, was a prespecified exploratory endpoint, and was assessed with the European Quality of Life 5-Dimensions 3
41                                           Clinical recovery was assessed with the global rating of change scale and Bosto
42 , and grown as monolayers; permeability in response to IL1B was assessed with the marker inulin.
43                                                   Cognition was assessed with the Penn Computerized Neurocognitive Batter
44                                         Probable RBD (pRBD) was assessed with the RBD Screening Questionnaire (RBDSQ) and
45                                     Oxygen consumption rate was assessed with the Seahorse metabolic flux analyzer, and m
46                                                      Angina was assessed with the Seattle Angina Questionnaire's angina f
47 nd Digit Span tests; whereas health-related quality of life was assessed with the SF36-HRQL test.
48                          Alcohol use following the infusion was assessed with timeline followback method, with abstinence
49        Possible association of collected variables with PEP was assessed with Univariate tests and multivariable logistic
50 ement for image quality and overall degree of visualization was assessed with weighted kappa.